Evidence map›Paper›PMID 41066145›Full record

ArticleEpilepsia2026

Syndromic and etiological classification predicts seizure freedom in childhood and youth onset epilepsy: A population-based study from the Norwegian Mother, Father, and Child Cohort Study.

Truls Vikin, Richard F Chin, Morten I Lossius, Dag Hofoss, Ragnhild E Brandlistuen, Kari M Aaberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Truls VikinNational Center for Epilepsy, Division of Clinical Neuroscience, full member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0009-0001-4536-9851
Richard F ChinRoyal Hospital for Children and Young People, Edinburgh, UK.ORCID https://orcid.org/0000-0002-7256-3027
Morten I LossiusNational Center for Epilepsy, Division of Clinical Neuroscience, full member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0000-0002-5982-7737
Dag HofossNational Center for Epilepsy, Division of Clinical Neuroscience, full member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0000-0002-6888-6333
Ragnhild E BrandlistuenNorwegian Institute of Public Health, Oslo, Norway.ORCID https://orcid.org/0000-0001-8054-0960
Kari M AabergNational Center for Epilepsy, Division of Clinical Neuroscience, full member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Oslo University Hospital, Oslo, Norway.

Funding

Foundation DamSouth-Eastern Norway Regional Health Authority
6 · The paper itself

Abstract

objectiveThis study was undertaken to determine the proportion of individuals with childhood and youth onset epilepsy who attain seizure freedom across seizure types, epilepsy types, etiologies, and syndromes using the latest International League Against Epilepsy (ILAE) classifications. Secondary objectives were to identify predictors of seizure freedom, evaluate time to last seizure among those achieving it, and estimate prevalence of active epilepsy.

methodsWe used data from the Norwegian Mother, Father, and Child Cohort Study, a nationwide population-based cohort of ~114 000 children born 1999-2009. Pediatric epileptologists validated and classified epilepsy cases through medical record review. Analyses included 1044 individuals with ≥12 months of follow-up. Seizure freedom was ≥12 months without seizures, with or without antiseizure medication (ASM), at end of follow-up. Predictors of seizure freedom were assessed using log-binomial regression adjusted for follow-up. Time to last seizure was analyzed using Accelerated Failure Time models. Active epilepsy at any age was defined as seizures during the preceding 2 years and/or ASM use at that age; prevalence was calculated annually from ages 0 to 18 years.

resultsMedian follow-up was 10.6 years. A total of 78% achieved seizure freedom. Predictors of reduced likelihood of seizure freedom included early (<2 years) or adolescent onset, multiple seizure types, status epilepticus, developmental comorbidities, and abnormal neurologic findings. Seizure freedom was most common in focal epilepsy (84%) and least in combined generalized and focal epilepsy (26%). It was highest for unknown etiology (89%) and lowest for structural (58%) and identified genetic etiologies (54%). Favorable outcomes were seen in self-limited focal epilepsies, childhood absence epilepsy, and self-limited infantile syndromes. Developmental and epileptic encephalopathies had lower rates. Among those seizure-free, median time to last seizure was 2.0 years. Prevalence peaked at age 11 years (490 per 100 000) and varied by syndrome. SIGNIFICANCE: This population-based study supports the prognostic value of syndrome- and etiology-based ILAE classifications in clinical care.

Indexed as

EpilepsySeizuresAdolescentAge of OnsetAnticonvulsantsChildChild, PreschoolCohort StudiesFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleNorwayAnticonvulsantschildhood epilepsyclinically validated epilepsyNorwegian Mother, Father, and Child Cohort Studyseizure freedom

Identifiers

PMID41066145
PMCPMC12927694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.